Logo image of JBIO

JADE BIOSCIENCES INC (JBIO) Stock Price, Quote, News and Overview

NASDAQ:JBIO - Nasdaq - US0080641071 - Common Stock - Currency: USD

9.89  +0.48 (+5.1%)

After market: 9.89 0 (0%)

JBIO Quote, Performance and Key Statistics

JADE BIOSCIENCES INC

NASDAQ:JBIO (6/20/2025, 8:00:02 PM)

After market: 9.89 0 (0%)

9.89

+0.48 (+5.1%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap318.85M
Shares32.24M
Float32.18M
Yearly DividendN/A
Dividend Yield849.34%
PEN/A
Fwd PEN/A
Earnings (Next)08-11 2025-08-11/amc
IPO06-30 2021-06-30


JBIO short term performance overview.The bars show the price performance of JBIO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

JBIO long term performance overview.The bars show the price performance of JBIO in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of JBIO is 9.89 USD. In the past month the price increased by 32.04%.

JADE BIOSCIENCES INC / JBIO Daily stock chart

JBIO Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.04 327.31B
AMGN AMGEN INC 13.94 155.58B
GILD GILEAD SCIENCES INC 14.02 134.97B
VRTX VERTEX PHARMACEUTICALS INC N/A 113.22B
REGN REGENERON PHARMACEUTICALS 11.5 55.03B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 40.38B
ARGX ARGENX SE - ADR 94.29 33.10B
ONC BEONE MEDICINES LTD-ADR 6.32 26.73B
BNTX BIONTECH SE-ADR N/A 25.61B
NTRA NATERA INC N/A 23.47B
INSM INSMED INC N/A 18.70B
BIIB BIOGEN INC 8.03 18.62B

About JBIO

Company Profile

JBIO logo image Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2021-06-30. The firm is in the process of exploring strategic alternatives, which may include, but are not limited to, an acquisition, merger, reverse merger, business combination, liquidation or other transaction.

Company Info

JADE BIOSCIENCES INC

930 Winter Street, Suite M-500

Waltham MASSACHUSETTS US

Employees: 4

JBIO Company Website

JBIO Investor Relations

Phone: 16174432400

JADE BIOSCIENCES INC / JBIO FAQ

What is the stock price of JADE BIOSCIENCES INC today?

The current stock price of JBIO is 9.89 USD. The price increased by 5.1% in the last trading session.


What is the ticker symbol for JADE BIOSCIENCES INC stock?

The exchange symbol of JADE BIOSCIENCES INC is JBIO and it is listed on the Nasdaq exchange.


On which exchange is JBIO stock listed?

JBIO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for JADE BIOSCIENCES INC stock?

11 analysts have analysed JBIO and the average price target is 18.36 USD. This implies a price increase of 85.64% is expected in the next year compared to the current price of 9.89. Check the JADE BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is JADE BIOSCIENCES INC worth?

JADE BIOSCIENCES INC (JBIO) has a market capitalization of 318.85M USD. This makes JBIO a Small Cap stock.


How many employees does JADE BIOSCIENCES INC have?

JADE BIOSCIENCES INC (JBIO) currently has 4 employees.


Should I buy JADE BIOSCIENCES INC (JBIO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does JADE BIOSCIENCES INC (JBIO) stock pay dividends?

JADE BIOSCIENCES INC (JBIO) has a dividend yield of 849.34%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of JBIO dividend history, reliability and sustainability.


When does JADE BIOSCIENCES INC (JBIO) report earnings?

JADE BIOSCIENCES INC (JBIO) will report earnings on 2025-08-11, after the market close.


What is the Price/Earnings (PE) ratio of JADE BIOSCIENCES INC (JBIO)?

JADE BIOSCIENCES INC (JBIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-59.5).


What is the Short Interest ratio of JADE BIOSCIENCES INC (JBIO) stock?

The outstanding short interest for JADE BIOSCIENCES INC (JBIO) is 0.74% of its float. Check the ownership tab for more information on the JBIO short interest.


JBIO Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to JBIO.


Chartmill TA Rating
Chartmill Setup Rating

JBIO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to JBIO. JBIO has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

JBIO Financial Highlights

Over the last trailing twelve months JBIO reported a non-GAAP Earnings per Share(EPS) of -59.5. The EPS increased by 44.08% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -63.15%
ROE -65.24%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%89.16%
Sales Q2Q%N/A
EPS 1Y (TTM)44.08%
Revenue 1Y (TTM)N/A

JBIO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to JBIO. The Buy consensus is the average rating of analysts ratings from 11 analysts.


Ownership
Inst Owners30.79%
Ins Owners0.06%
Short Float %0.74%
Short Ratio0.73
Analysts
Analysts81.82
Price Target18.36 (85.64%)
EPS Next Y92.32%
Revenue Next YearN/A